This page in English
Laddar profil information

Publikationer

Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment
Scharenberg C, Jansson M, Saft L, Hellström-lindberg E
British journal of haematology 2018;180(4):526-533

Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia
Mujahed H, Jansson M, Bengtzén S, Lehamnn S
Blood cancer journal 2017;7(10):e616-

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
Tobiasson M, Abdulkadir H, Lennartsson A, Katayama S, Marabita F, De Paepe A, et al
Oncotarget 2017;8(17):28812-28825

SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Mortera-blanco T, Dimitriou M, Woll Ps, Karimi M, Elvarsdottir E, Conte S, et al
Blood 2017;130(7):881-890

Mutations in histone modulators are associated with prolonged survival during azacitidine therapy
Tobiasson M, Mclornan Dp, Karimi M, Dimitriou M, Jansson M, Ben Azenkoud A, et al
Oncotarget 2016;7(16):22103-15

Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
Conte S, Katayama S, Vesterlund L, Karimi M, Dimitriou M, Jansson M, et al
British journal of haematology 2015;171(4):478-90

FISH Detection of X and Y Chromosomes in Combination with Immunofluorescence to Study Contribution of Transplanted Cells to Skeletal Muscle Fibers
Strömberg A, Jansson M
Methods in molecular biology (Clifton, N.J.) 2015;1313():131-9

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Karimi M, Nilsson C, Dimitriou M, Jansson M, Matsson H, Unneberg P, et al
Haematologica 2015;100(6):e223-5

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M, et al
Blood 2015;126(2):233-41

Azacitidine induces profound genome-wide hypomethylation in primary myelodysplastic bone marrow cultures but may also reduce histone acetylation
Grövdal M, Karimi M, Tobiasson M, Reinius L, Jansson M, Ekwall K, et al
Leukemia 2014;28(2):411-3

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
Tobiasson M, Dybedahl I, Holm Ms, Karimi M, Brandefors L, Garelius H, et al
Blood cancer journal 2014;4():e189-

Bone marrow derived cells in adult skeletal muscle tissue in humans
Strömberg A, Jansson M, Fischer H, Rullman E, Hägglund H, Gustafsson T
Skeletal muscle 2013;3(1):12-

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
Nikpour M, Scharenberg C, Liu A, Conte S, Karimi M, Mortera-blanco T, et al
Leukemia 2013;27(4):889-896

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Mollgard L, Saft L, Treppendahl Mb, Dybedal I, Norgaard Jm, Astermark J, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2011;96(7):963-71

Clinical impact of chromosomal aberrations in multiple myeloma
Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G
JOURNAL OF INTERNAL MEDICINE 2011;269(2):137-47

Constitutional inv(3) in myelodysplastic syndromes
Gahrton C, Nahi H, Jansson M, Wallblom A, Alici E, Sutlu T, et al
LEUKEMIA RESEARCH 2010;34(12):1627-9

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia
Deneberg S, Grovdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A, et al
LEUKEMIA 2010;24(5):932-41

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation
Paul E, Sutlu T, Deneberg S, Alici E, Bjorkstrand B, Jansson M, et al
ONCOLOGY REPORTS 2009;22(1):137-42

Lenalidomide abrogates the clonal advantage of del(5q) MDS stem cells via alteration of niche interactions
Scharenberg C, Jadersten M, Palmquist J, Forsblom L, Jansson M, Hellstrom-lindberg E
LEUKEMIA RESEARCH 2009;:S48-S48

LENALIDOMIDE ABROGATES THE CLONAL ADVANTAGE OF DEL(5Q) MDS STEM CELLS VIA ALTERATION OF NICHE INTERACTIONS
Scharenberg C, Jadersten M, Palmquist J, Forsblom L, Jansson M, Hellstrom-lindberg E
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;:98-98

Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
Groevdal M, Kahn R, Jansson M, Aggerholm A, Antunovic P, Astermark J, et al
LEUKEMIA RESEARCH 2009;:S49-S50

The prognostic significance of 8p21 deletion in multiple myeloma
Sutlu T, Alici E, Jansson M, Wallblom A, Dilber Ms, Gahrton G, et al
BRITISH JOURNAL OF HAEMATOLOGY 2009;144(2):266-8

Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS
Deneberg S, Grovdall M, Jansson M, Gaidzik Vi, Corbacioglu A, Nahi H, et al
BLOOD 2008;112(11):1146-1147

Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient
Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, Hassan M, et al
HUMAN REPRODUCTION 2008;23(1):139-43

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
Sadeghi B, Jansson M, Hassan Z, Mints M, Hagglund H, Abedi-valugerdi M, et al
BONE MARROW TRANSPLANTATION 2008;41(10):895-904

Transmission of chronic lymphocytic leukaemia from a blood stem cell sibling donor to the recipient
Nahi H, Jansson M, Sander B, Ljungman P, Hagglund H
BRITISH JOURNAL OF HAEMATOLOGY 2008;143(5):751-3

Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice
Nilsson C, Forsman J, Hassan Z, Abedi-valugerdi M, O'connor C, Concha H, et al
EXPERIMENTAL HEMATOLOGY 2005;33(3):380-7

Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
Le Blanc K, Gotherstrom C, Ringden O, Hassan M, Mcmahon R, Horwitz E, et al
TRANSPLANTATION 2005;79(11):1607-14

Investigating cyclin B1 positive subpopulation in Mantle cell lymphoma using FICTION on paraffin embedded tissue
Emanuelsson Ek, Jansson M, Fahlstrom G, Hassan M, Sander B
CHROMOSOME RESEARCH 2005;:180-180

Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation
Mattson J, Jansson M, Wernerson A, Hassan M
TRANSPLANTATION 2004;78(1):154-7

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14
Kapanadze B, Makeeva N, Corcoran M, Jareborg N, Hammarsund M, Baranova A, et al
GENOMICS 2000;70(3):327-34

Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates
Wu Xs, Ivanova G, Merup M, Jansson M, Stellan B, Grander D, et al
GENOMICS 1999;60(2):161-71

Structure and chromosomal assignment of the sterol 12 alpha-hydroxylase gene (CYP8B1) in human and mouse: Eukaryotic cytochrome P-450 gene devoid of introns
Gafvels M, Olin M, Chowdhary Bp, Raudsepp T, Andersson U, Persson B, et al
GENOMICS 1999;56(2):184-96

A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia - comparison with cytogenetics and Southern hybridization
Merup M, Jansson M, Corcoran M, Liu Y, Wu X, Rasool Oz, et al
LEUKEMIA 1998;12(5):705-9

Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia
Merup M, Juliusson G, Xu Xh, Jansson M, Stellan B, Rasool O, et al
EUROPEAN JOURNAL OF HAEMATOLOGY 1997;58(3):174-80

Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint
Wu Xs, Merup M, Juliusson G, Jansson M, Stellan B, Grander D, et al
GENES CHROMOSOMES & CANCER 1997;20(4):337-46

Visa alla publikationer

Karta